Cita APA

Kumar, S., Jang, H. C., Demirağ, N. G., Skjøth, T. V., Endahl, L., & Bode, B. (2016). Efficacy and safety of once‐daily insulin degludec/insulin aspart compared with once‐daily insulin glargine in participants with Type 2 diabetes: A randomized, treat‐to‐target study. Diabet Med.

Citación estilo Chicago

Kumar, S., H. C. Jang, N. G. Demirağ, T. V. Skjøth, L. Endahl, and B. Bode. "Efficacy and Safety of Once‐daily Insulin Degludec/insulin Aspart Compared With Once‐daily Insulin Glargine in Participants With Type 2 Diabetes: A Randomized, Treat‐to‐target Study." Diabet Med 2016.

Cita MLA

Kumar, S., et al. "Efficacy and Safety of Once‐daily Insulin Degludec/insulin Aspart Compared With Once‐daily Insulin Glargine in Participants With Type 2 Diabetes: A Randomized, Treat‐to‐target Study." Diabet Med 2016.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.